Artiben Baldevbhai Prajapati
About Artiben Baldevbhai Prajapati
Data last updated:
Artiben Baldevbhai Prajapati is a Director at Gopsi Pharma Private Limited (since 2015) and Director at Padmasiddha Healthcare Private Limited (since 2022). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹8.78 Cr; the largest is Gopsi Pharma Private Limited at ₹7.43 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gopsi Pharma Private Limited U24232GJ1997PTC031585 | Director | 18 Feb 2015 | 1997 | ₹7.43 Cr (FY 2023) | Active |
 Padmasiddha Healthcare Private Limited U85110GJ2022PTC130003 | Director | 10 Mar 2022 | 2022 | ₹1.35 Cr (FY 2025) | Active |
Board colleagues of Artiben Baldevbhai Prajapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Baldevbhai Govindbhai Prajapati | 01496198 | Gopsi Pharma Private Limited | Director |
| Prajapati Vikasbhai Baldevbhai | 06587730 | Gopsi Pharma Private Limited | Director |
| Prasmit Amit Shah | 09077873 | Padmasiddha Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Artiben Baldevbhai Prajapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artiben Baldevbhai Prajapati
Artiben Baldevbhai Prajapati currently holds 2 directorships: Gopsi Pharma Private Limited (Director, since 18 Feb 2015, revenue ₹7.43 Cr (FY 2023)); Padmasiddha Healthcare Private Limited (Director, since 10 Mar 2022, revenue ₹1.35 Cr (FY 2025)).
Artiben Baldevbhai Prajapati was first appointed on 18 Feb 2015 as Director at Gopsi Pharma Private Limited. The most recent appointment on record is 10 Mar 2022 at Padmasiddha Healthcare Private Limited.
The 2 current companies of Artiben Baldevbhai Prajapati that report revenue have a combined latest revenue of ₹8.78 Cr: Gopsi Pharma Private Limited ₹7.43 Cr (FY 2023); Padmasiddha Healthcare Private Limited ₹1.35 Cr (FY 2025).
The current boards of Artiben Baldevbhai Prajapati's companies include Baldevbhai Govindbhai Prajapati (Gopsi Pharma Private Limited), Prajapati Vikasbhai Baldevbhai (Gopsi Pharma Private Limited), Prasmit Amit Shah (Padmasiddha Healthcare Private Limited).